SPINOCEREBELLAR ATAXIA 2 (SCA2) DNA DETECTION, EDTA BLOOD

image not found

NABL Cap Accredited   
The SCA2 DNA Detection test identifies abnormal CAG repeat expansions in the ATXN2 gene, which cause Spinocerebellar Ataxia Type 2. This inherited neurodegenerative disorder leads to progressive balance issues, coordination problems, slow eye movements, and muscle weakness. Using EDTA blood, the test accurately measures repeat size to confirm the genetic diagnosis. Early detection supports appropriate clinical management, prognosis assessment, and genetic counseling for affected families

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,275.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: S0003

Frequently Asked Questions (FAQ's):

What does the SCA2 DNA test detect?
It detects CAG repeat expansions in the ATXN2 gene associated with Spinocerebellar Ataxia Type 2.

Who should consider this test?
Individuals showing symptoms of ataxia or those with a known family history of SCA2.

Which sample is required?
EDTA blood is required for DNA extraction and analysis.

Does this test confirm the condition?
Yes, it offers a definitive genetic diagnosis for SCA2.

Is any preparation needed?
No fasting or special preparation is required.

How does the result help?
The result guides diagnosis, treatment planning, and long-term care strategies.

Can family members be tested?
Yes, once the mutation is identified, predictive or carrier testing can be offered to relatives.

Is this test available at Metropolis Healthcare?
Yes, Metropolis Healthcare provides SCA2 genetic testing using validated molecular methods

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab